caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1730177114

Humam KakishM.D.

PRACTICEADVANCED VEIN & VASCULAR ASSOCIATESSee all providers at this practice →
Vascular SurgeryDallas, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Humam Kakish's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS109258
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
3654
Swdic Imaging Center Partnership, Llp
Independent Diagnostic Testing Facility (IDTF) · Dallas, TX
3550
TONREY, FRANK2473
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
2231
Byung Park
Interventional Cardiology · Dallas, TX
1353
Kelly Campbell
Physician Assistant · Dallas, TX
1123
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,203
Unique beneficiaries
—
Total services
1,439
Distinct HCPCS
16
Medicare payment
$173K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 273 Vascular Surgery providers in TX — top quintile (cohort median 854).
QUALITY · MIPS · 2024
Final MIPS score
0.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-9.00%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
254
Beneficiaries
—
Total drug cost
$37K
Distinct drugs
6
Brand share
73.6%
Top prescribed drugs
Clopidogrel Bisulfate132 claims
Apixaban44 claims
Tramadol Hcl42 claims
Cilostazol14 claims
Prasugrel Hcl11 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.